Famitinib Active Not Recruiting Phase 2 Trials for Metastatic Breast Cancer / Advanced Breast Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04733417A Study of SHR6390 Combined With Famitinib in the Treatment of HR + / HER2- Advanced Breast Cancer.